"
Clinical Utility of Procalcitonin for Differentiating between Cryptogenic Organizing Pneumonia and Community-Acquired Pneumonia"
written by Satoshi Takeda, Nobuhiko Nagata, Hiroyuki Miyazaki, Takanori Akagi, Taishi Harada, Masaru Kodama, Shinichiro Ushijima, Takashi Aoyama, Kentaro Wakamatsu, Masaki Fujita, Kentaro Watanabe,
published by
International Journal of Clinical Medicine,
Vol.6 No.6, 2015
has been cited by the following article(s):
|
[1]
|
Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital
BMC Geriatrics,
2019
DOI:10.1186/s12877-018-1008-8
|
|
|
|
|
[2]
|
Procalcitonin-guided antibiotic discontinuation might shorten the duration of antibiotic treatment without increasing pneumonia recurrence
The American Journal of the Medical Sciences,
2019
DOI:10.1016/j.amjms.2019.04.005
|
|
|
|
|
[3]
|
Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia
Clinical Chemistry and Laboratory Medicine (CCLM),
2019
DOI:10.1515/cclm-2019-0175
|
|
|
|
|
[4]
|
Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia
Clinical Chemistry and Laboratory Medicine (CCLM),
2019
DOI:10.1515/cclm-2019-0175
|
|
|
|
|
[5]
|
Cryptogenic organising pneumonia presenting with spontaneous pneumothorax and the value of procalcitonin: A case report
Respiratory Medicine Case Reports,
2017
DOI:10.1016/j.rmcr.2017.06.006
|
|
|
|